Existing drugs could treat chikungunya

August 25, 2017, Agency for Science, Technology and Research (A*STAR), Singapore
The degree of subcutaneous edema during Chikungunya infection (top) and the fingolimod treated mice (bottom) during the peak of joint swelling. Credit: Ref. 1. © Teo et al., American Association for the Advancement of Science

Chikungunya virus (CHIKV) infection could be treated with autoimmune therapies currently used for other conditions, according to research led by A*STAR scientists. 

When transmitted to humans by mosquitoes, CHIKV causes high fever, headaches, and debilitating joint pain. Since 2004 there have been major outbreaks in Africa, Asia, the Caribbean, and South and Central America. There are currently no approved treatments. 

A group led by Lisa F. P. Ng at the A*STAR Singapore Immunology Network (SIgN) demonstrated in 2013 that CD4+ T cells, which mediate immune system responses, play a central role in triggering CHIKV-induced joint swelling. 

To investigate, Ng and Laurent Renia, her colleague at SIgN led the team to transfer CD4+ T cells from both healthy and CHIKV-infected mice into T cell receptor-deficient mice. Only those that received cells from infected donors suffered joint swelling, inflammation and skeletal muscle damage—confirming the key role of these T cells in triggering CHIKV symptoms. 

They then carried out proteome wide screening assays in which CD4+ T cells taken from CHIKV-infected mice were tested against all proteins generated by the CHIKV virus. 

This identified specific segments in two viral proteins, nsP1 and E2, as those that stimulate CD4+ T cell responses to CHIKV. The discovery could be used to help design vaccines against CHIKV and related viruses. 

Applying their findings, the researchers treated groups of CHIKV-infected mice with three clinically-approved T cell suppressive drugs. Tissue samples were then visually assessed by histopathologists. 

Fingolomid, usually used to prevent multiple sclerosis relapses, successfully reduced joint swelling, inflammation and muscle damage in the rodents. It did so both when given as a prophylactic, and following infection as a standard therapeutic treatment. The other two drugs—cyclosporin A and rapamycin—failed to control the disease symptoms in mice. 

Ng and her colleagues stress that the use of fingolomid to treat CHIKV patients with chronic joint pain has yet to be evaluated, but hope their study will lead to further research on whether it and other immunosuppressive drugs could help those with the condition. 

"We were pleased with these findings," says Ng. "They demonstrate our previous theory about the pathogenic role of CD4+ T cells was correct, and suggest existing T cell suppressive drugs could provide viable treatment options for patients." 

The group believes such drugs could also be used to treat inflammation caused by other arthropod-spread viruses that is mediated by virus-specific CD4+ T .

Explore further: First Chikungunya-infected Aedes aegypti mosquitos found in Brazil

More information: Teck-Hui Teo et al. Fingolimod treatment abrogates chikungunya virus–induced arthralgia, Science Translational Medicine (2017). DOI: 10.1126/scitranslmed.aal1333

Related Stories

First Chikungunya-infected Aedes aegypti mosquitos found in Brazil

June 22, 2017
While more than 13,000 cases of Chikungunya viral disease were reported in Brazil in 2015, scientists had never before detected the virus in a captured mosquito in this country. Now, researchers reporting in PLOS Neglected ...

A cell surface protein known to regulate innate immune responses also affects the adaptive immune system

April 15, 2015
Understanding the immune response triggered by the mosquito-borne Chikungunya virus (CHIKV) is key to developing effective treatments. Now, an international team led by A*STAR researchers has shown that a cell surface protein—the ...

Chikungunya test also distinguishes the illness from other mosquito-borne diseases

October 21, 2015
A detection assay that identifies the presence of viral-specific antibodies in patients with Chikungunya virus (CHIKV) has been developed by A*STAR researchers. The technique can also help differentiate between CHIKV and ...

Details of monkey antibodies against chikungunya virus could help to fight the disease in humans

September 24, 2014
Chikungunya fever can cause severe and long-lasting joint pain, with several epidemics affecting multiple continents in the past decade. The illness is caused by chikungunya virus (CHIKV), but there is no effective vaccine ...

Virology: Seeking solutions to viral migration

July 3, 2013
Although seldom fatal, persistent infection by chikungunya virus (CHIKV) afflicts patients with joint pain lasting months or even years. This insect-borne virus has received relatively little scientific attention in the 50 ...

Exploiting the early immune response in Chikungunya fever promises to provide protection

July 4, 2012
(Medical Xpress) -- Chikungunya fever is a viral disease that has re-emerged to cause epidemics in the Pacific region within the last decade. It is caused by the Chikungunya virus (CHIKV), which is transmitted by mosquitoes ...

Recommended for you

Scientists a step closer to predicting epidemics

July 13, 2018
Ecologists at the University of Georgia have taken an important step in their efforts to develop an early warning system for infectious disease outbreaks.

Researchers identify target for novel malaria vaccine

July 13, 2018
A Yale-led team of researchers have created a vaccine that protects against malaria infection in mouse models, paving the way for the development of a human vaccine that works by targeting the specific protein that parasites ...

Higher income and being married protect older people from broken bones

July 13, 2018
Research led by scientists from the Medical Research Council Lifecourse Epidemiology Unit (MRC LEU) at the University of Southampton has shown that a higher income and being married reduces the risk of experiencing a broken ...

Gammaherpesviruses linked to tumors in macaques with simian immunodeficiency virus

July 12, 2018
Viruses known as gammaherpesviruses may raise the risk of cancer in macaques infected with Simian Immunodeficiency Virus or Simian Human Immunodeficiency Virus (SIV/SHIV), according to new research published by Vickie Marshall ...

Scientists find protein exploited by virus ravaging West Africa

July 12, 2018
A research team from several institutions being led by the University of California San Diego has deciphered a key component behind a rising epidemic of pathogens that the World Health Organization (WHO) recently added to ...

How a Mediterranean diet could reduce osteoporosis

July 11, 2018
Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis—according to new research from the University of East Anglia.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.